New biotech spinoff emerges from Anhui Anke, Shanghai Newsummit ¥55M JV
HONG KONG – A Chinese biotechnology company is leading a group of investors, including many of its own top executives, in a joint venture to develop a sought-after drug used to regenerate skin cells in burn victims.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter